| pubmed-article:7587907 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:7587907 | lifeskim:mentions | umls-concept:C0008972 | lld:lifeskim |
| pubmed-article:7587907 | lifeskim:mentions | umls-concept:C0011849 | lld:lifeskim |
| pubmed-article:7587907 | lifeskim:mentions | umls-concept:C0014792 | lld:lifeskim |
| pubmed-article:7587907 | lifeskim:mentions | umls-concept:C0003968 | lld:lifeskim |
| pubmed-article:7587907 | lifeskim:mentions | umls-concept:C0456603 | lld:lifeskim |
| pubmed-article:7587907 | lifeskim:mentions | umls-concept:C0301630 | lld:lifeskim |
| pubmed-article:7587907 | lifeskim:mentions | umls-concept:C1517004 | lld:lifeskim |
| pubmed-article:7587907 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:7587907 | pubmed:dateCreated | 1995-12-7 | lld:pubmed |
| pubmed-article:7587907 | pubmed:abstractText | In order to confirm the effect of ascorbic acid (AA) on human erythrocyte sorbitol accumulation and explore its mechanism of action, the effects of ascorbic acid in vitro on the sorbitol (S) and glucose (EG) content of human erythrocytes and in particular on the S/EG ratio as a marker of aldose reductase (AR) activity were carefully observed. The results showed that both the accumulation of erythrocyte sorbitol and the S/EG ratio were strongly reduced by the addition of AA. The sorbitol content in the erythrocyte and the S/EG ratio were reduced by a maximum of 87.3% and 83.4% and 93.8% and 63.9% when the medium's AA concentration was at its peak with 5.6 mmol/l and 28 mmol/l glucose in the medium, respectively. The contents of erythrocyte glucose measured coincidentally revealed a positive correlation with the ascorbic acid concentration in the medium during incubation in 5.6 mmol/l glucose while at a higher glucose level (28 mmol/l) in the medium the correlation became negative. These results suggested that the polyol pathway could be inhibited effectively by AA through its direct action on AR. The results of a double-blind cross-over trial using AA tablets or inositol tablets in eight diabetic patients showed that the supplementation of 1000 mg AA/day for 2 weeks resulted in reductions of 12.2% and 21.8% in erythrocyte sorbitol and red cell sorbitol/plasma glucose (S/PG) ratio, respectively (P < 0.05), whereas the fasting plasma glucose levels measured coincidentally revealed no changes (P > 0.05).(ABSTRACT TRUNCATED AT 250 WORDS) | lld:pubmed |
| pubmed-article:7587907 | pubmed:language | eng | lld:pubmed |
| pubmed-article:7587907 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7587907 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:7587907 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7587907 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7587907 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7587907 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:7587907 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:7587907 | pubmed:issn | 0168-8227 | lld:pubmed |
| pubmed-article:7587907 | pubmed:author | pubmed-author:WangHH | lld:pubmed |
| pubmed-article:7587907 | pubmed:author | pubmed-author:ChenJ WJW | lld:pubmed |
| pubmed-article:7587907 | pubmed:author | pubmed-author:ZhangZ BZB | lld:pubmed |
| pubmed-article:7587907 | pubmed:author | pubmed-author:WenR RRR | lld:pubmed |
| pubmed-article:7587907 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:7587907 | pubmed:volume | 28 | lld:pubmed |
| pubmed-article:7587907 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:7587907 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:7587907 | pubmed:pagination | 1-8 | lld:pubmed |
| pubmed-article:7587907 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:7587907 | pubmed:meshHeading | pubmed-meshheading:7587907-... | lld:pubmed |
| pubmed-article:7587907 | pubmed:meshHeading | pubmed-meshheading:7587907-... | lld:pubmed |
| pubmed-article:7587907 | pubmed:meshHeading | pubmed-meshheading:7587907-... | lld:pubmed |
| pubmed-article:7587907 | pubmed:meshHeading | pubmed-meshheading:7587907-... | lld:pubmed |
| pubmed-article:7587907 | pubmed:meshHeading | pubmed-meshheading:7587907-... | lld:pubmed |
| pubmed-article:7587907 | pubmed:meshHeading | pubmed-meshheading:7587907-... | lld:pubmed |
| pubmed-article:7587907 | pubmed:meshHeading | pubmed-meshheading:7587907-... | lld:pubmed |
| pubmed-article:7587907 | pubmed:meshHeading | pubmed-meshheading:7587907-... | lld:pubmed |
| pubmed-article:7587907 | pubmed:meshHeading | pubmed-meshheading:7587907-... | lld:pubmed |
| pubmed-article:7587907 | pubmed:meshHeading | pubmed-meshheading:7587907-... | lld:pubmed |
| pubmed-article:7587907 | pubmed:meshHeading | pubmed-meshheading:7587907-... | lld:pubmed |
| pubmed-article:7587907 | pubmed:meshHeading | pubmed-meshheading:7587907-... | lld:pubmed |
| pubmed-article:7587907 | pubmed:meshHeading | pubmed-meshheading:7587907-... | lld:pubmed |
| pubmed-article:7587907 | pubmed:meshHeading | pubmed-meshheading:7587907-... | lld:pubmed |
| pubmed-article:7587907 | pubmed:year | 1995 | lld:pubmed |
| pubmed-article:7587907 | pubmed:articleTitle | Experimental and clinical studies on the reduction of erythrocyte sorbitol-glucose ratios by ascorbic acid in diabetes mellitus. | lld:pubmed |
| pubmed-article:7587907 | pubmed:affiliation | Department of Endocrinology, First Affiliated Hospital, Nanjing Medical University, Jiangsu, People's Republic of China. | lld:pubmed |
| pubmed-article:7587907 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:7587907 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:7587907 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:7587907 | pubmed:publicationType | In Vitro | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7587907 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7587907 | lld:pubmed |
